The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The vascular grafts market has witnessed significant growth in recent years, fueled by various factors, and is poised for continued expansion in the foreseeable future.

Recent Market Growth

• Market Size: Increased from $3.21 billion in 2023 to $3.5 billion in 2024.
• Growth Rate: A compound annual growth rate (CAGR) of 9.3%.
• Contributing Factors:
  • Rise in cardiovascular diseases (CVDs).
  • Increased geriatric population.
  • Economic growth in emerging markets.
  • Rise in healthcare expenditure.
  • Expansion of healthcare facilities.

View More On The Vascular Grafts Market Report 2024 – https://www.thebusinessresearchcompany.com/report/vascular-grafts-global-market-report

Future Market Outlook

• Expected Growth: Projected to reach $4.67 billion by 2028.
• Future CAGR: Anticipated to grow at a CAGR of 7.4%.
• Growth Drivers:
  • Increasing prevalence of renal diseases.
  • Rise in hypertension prevalence.
  • Sedentary lifestyles.
  • Rapid growth in the geriatric population.
  • Increase in diabetes cases.
  • Continued prevalence of CVDs.
  • Rise in healthcare expenditure.

Key Trends in the Forecast Period

• Technological Investments: Companies are investing in the latest technology to improve vascular graft compliance and success rates.
• 3D Cell Printing: Advancements in 3D cell printing for safer and more successful grafts.
• Cell-Free Vascular Grafts: Development and utilization of cell-free vascular grafts.
• Monitoring Technology: Investment in smart patches and self-monitoring devices.
• Research and Development: Focus on innovation for improved patient care.

Prevalence of Vascular Diseases

• Global Impact: Vascular diseases are a leading cause of death worldwide, according to studies by various health organizations.
• Statistics: The American Heart Association reports millions of annual cases of myocardial infarction in the US alone, with thousands of coronary bypass grafts performed annually in England.

Major Players in the Market

• Key Companies:
  • Braun Melsungen AG
  • Abbott Laboratories
  • Becton Dickinson and Company
  • Cardinal Health Inc.
  • L. Gore & Associates Inc.
  • Terumo Medical Corporation
  • Medtronic PLC
  • Getinge
  • Endologix
  • Cook Medical
  • MicroPort
  • CR Bard
  • Biovic
  • Creganna
  • Novomed Incorporation Private Limited

Investment in Technological Advancements

• Focus on Innovation: Companies are increasingly investing in technological advancements to develop innovative and customized vascular grafts.
• Example: Terumo Aortic’s RelayPro, a thoracic stent graft system, offers customization options for treating thoracic endovascular aortic repair (TEVAR) patients with smaller access vessels.

Strategic Acquisitions

• Gore & Associates Acquisition: In August 2022, Gore & Associates acquired InnAVasc Medical Inc., a manufacturer of vascular grafts for hemodialysis, aiming to improve patient outcomes in dialysis treatment.

Market Segmentation

• By Product:
  • Hemodialysis Access Graft
  • Endovascular Stent Graft
  • Peripheral Vascular Graft
  • Coronary Artery By-pass Graft
• By Raw Material:
  • Polyester Grafts
  • Polytetrafluoroethylene Grafts
  • Polyurethane Grafts
  • Biosynthetic Grafts
• By Application:
  • Coronary Artery Disease
  • Aneurysm
  • Vascular Occlusion
  • Renal Failure
• By End-User:
  • Hospitals
  • Ambulatory Surgical Centers

Regional Insights

• Dominant Region: North America led the vascular grafts market in 2023.

The vascular grafts market continues to expand rapidly, driven by technological advancements, increasing prevalence of vascular diseases, and strategic investments by key players. With a focus on innovation and customization, the market is poised for further growth and development in the coming years.

Request A Sample Of The Global Vascular Grafts Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=3419&type=smp